The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 359:2289-2293 November 20, 2008 Number 21
NextNext

Quality of Life with PCI versus Medical Therapy in Stable Coronary Disease

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Peterson, E. D.
-Related Article
by Weintraub, W. S.
-PubMed Citation
To the Editor: Weintraub et al. (Aug. 14 issue)1 report the results of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial, which examined the effect of percutaneous coronary intervention (PCI), as compared with medical therapy alone, on the quality of life in patients with stable coronary disease. The Seattle Angina Questionnaire (SAQ), as well as other measures, was used to assess the effect of treatment on health status. The authors conclude that patients who received PCI had small but significant incremental benefits that disappeared by 36 months.

Concern has been expressed about the generalizability of the results . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.